Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Immunology|March 5, 2024
Incidence and predictors of infections in patients with advanced non-small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort studyDavide Fiore Bavaro, Lucia Diella, Pamela Pizzutilo, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future PerspectivesDavide Fiore Bavaro, Alessandra Belati, Lucia Diella, et al.
Antibiotics (Basel, Switzerland)|November 11, 2022
Prompt and Appropriate Antimicrobial Therapy Improves Outcomes of NDM-Producing and KPC-Producing Klebsiella pneumoniae Bloodstream Infections in Patients Hospitalized for COVID-19: A Comparative Retrospective Case-SeriesDavide Fiore Bavaro, Alessandra Belati, Lucia Diella, et al.
Antibiotics (Basel, Switzerland)|June 28, 2023
Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center StudyLidia Dalfino, Monica Stufano, Davide Fiore Bavaro, et al.
Internal and Emergency Medicine|November 30, 2022
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patientsFrancesco Di Gennaro, Alessandra Belati, Ottavia Tulone, et al.
Medicina (Kaunas, Lithuania)|February 25, 2023
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot StudySebastiano Cicco, Marialuisa Sveva Marozzi, Carmen Alessandra Palumbo, et al.
International Journal of Antimicrobial Agents|June 21, 2024
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort StudyAlessandra Belati, Lucia Diella, Davide Fiore Bavaro, et al.
British Journal of Haematology|June 1, 2023
Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohortCarla Minoia, Lucia Diella, Tommasina Perrone, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2024
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort studyEmanuele Rando, Federica Salvati, Flavio Sangiorgi, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2023
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort studyDavide Fiore Bavaro, Alessandra Belati, Lucia Diella, et al.
Pageof 4